Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic
Administration of 2-PMPA (50mg/kg) produces a mean peak concentration of 2-PMPA of 29
4-Dihydroxy-2-carbomethoxy-3-prenylnaphthalene-1-O-β-D-glucopyranoside has no cytotoxicity with A549
triacylglycerol and the total cholesterol content are decreased
(S, R, S)-AHPC-PEG1-NH2 Catalog No.:M13497-10 The development of antiretroviral therapy(S,R,S) AHPC PEG1 NH2 (VH032 PEG1 NH2) is a synthesized E3 ligase ligand linker conjugate that incorporates the VH032 based VHL ligand and a linker used in PROTAC technology. Product information CAS Number: 2241641 57 4 Molecular Weight: 531. 67 Formula: C26H37N5O5S Chemical Name: (2S,4R) 1 [(2S) 2 [2 (2 aminoethoxy)acetamido] 3,3 dimethylbutanoyl] 4 hydroxy N {[4 (4 methyl 1,3 thiazol 5 yl)phenyl]methyl}pyrrolidine 2 carboxamide Smiles: